Abstract:Programmed cell death (PCD) is an essential part of organismal development and plays fundamental roles in host defense against pathogens and the maintenance of homeostasis. However, excess activation of PCD pathways has proven to be detrimental and can drive disease. Additionally, resistance to PCD can also contribute to disease development. Modulation of PCD, therefore, has great therapeutic potential in a wide range of diseases, including infectious, neurodegenerative, autoinflammatory, and metabolic diseases and cancer. Nevertheless, manipulation of cell death and inflammation for therapeutic intervention is a delicate process, highly specific to the context of the disease of interest, making the selection of the appropriate target molecule crucially important. Several PCD pathways are associated with innate immunity, including pyroptosis, apoptosis, necroptosis, and PANoptosis, which is defined as an inflammatory PCD pathway with key features of pyroptosis, apoptosis, and/or necroptosis that cannot be accounted for by any of these three PCD pathways alone. All of these PCD pathways are regulated by upstream sensors and signaling cascades that assemble multimeric complexes to serve as activation platforms for downstream molecules; these sensors and signaling molecules provide attractive target points for therapeutic intervention. Here, we discuss the molecular mechanisms of innate immune-mediated cell death in health and disease, with a particular focus on the molecules putatively involved in the formation of the PANoptosome and the induction of inflammatory cell death. Further, we discuss the implications and feasibility of targeting these molecules to improve disease outcomes, as well as current clinical approaches.

Navigating the complexities of cell death: Insights into accidental and programmed cell death

Cell death pathways: intricate connections and disease implications

Diversity and complexity of cell death: a historical review

The Mechanisms of Regulated Cell Death: Structural and Functional Proteomic Pathways Induced or Inhibited by a Specific Protein-A Narrative Review

Programmed cell death: molecular mechanisms, biological functions, diseases, and therapeutic targets

Types of Cell Death from a Molecular Perspective

Emerging connectivity of programmed cell death pathways and its physiological implications

The molecular machinery of regulated cell death

Programmed Cell Death, from a Cancer Perspective: An Overview

Accidental and Programmed Cell Death in Investigative and Toxicologic Pathology

Cell death: a review of the major forms of apoptosis, necrosis and autophagy

Different types of cell death and their shift in shaping disease

Dissecting Cell Death with Proteomic Scalpels

Programming inflammatory cell death for therapy

Programmed Cell Death and Cancer

Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis.

Significance of Programmed Cell Death Pathways in Neurodegenerative Diseases

Using Small Molecules to Dissect Non‐apoptotic Programmed Cell Death: Necroptosis, Ferroptosis, and Pyroptosis

Programmed Cell Death: Complex Regulatory Networks in Cardiovascular Disease

Programmed cell death - strategy for maintenance cellular organisms homeostasis

Anti-apoptosis and cell survival: A review